Evaluation of Recombinant Antibodies Produced in the Expi293 and ExpiCHO (Thermo) Expression Systems for Use in Immunoassays
Abstract
Recombinant thermostable antibodies against the MS2 virus and botulinum neurotoxin A (Bot A) hemagglutinin 33 (HA33) were produced in large scale using transient transfections in mammalian cell lines. After validation of immunoglobulin G binding activity and thermostability was completed, antibodies were assessed for suitability of toxin detection immunoassays with recombinant protein and Bot A toxoid targets on the MAGPIX (Luminex Corporation; Austin, TX) platform.
Document Details
- Document Type
- Technical Report
- Publication Date
- Dec 01, 2020
- Accession Number
- AD1118262
Entities
People
- Darrel Menking
- Elizabeth Vincente
- Eric Schaffer
- Heather Welsh
- Katherine Rhea
- Melody Zacharko
- Randy Hofmann
- Robert W. Dorsey
- Tomotaka Mido
Organizations
- Leidos